Apyx Medical Corp — Director's Dealing 2021

Feb 12, 2021

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Apyx Medical Corp (APYX)
CIK: 0000719135
Period of Report: 2020-12-31

Reporting Person: Swandal Craig A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-04	Common Stock	M	9916	$7.28	Acquired	17000	Direct
2020-10-07	Common Stock	M	7084	$7.28	Acquired	17000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-04	Stock Option (Option to Buy)	$7.28	M	9916	Disposed	2029-08-01	Common Stock (9916.0)	Direct
2020-10-07	Stock Option (Option to Buy)	$7.28	M	7084	Disposed	2029-08-01	Common Stock (7084.0)	Direct

Footnotes

F1: The transactions reported reflect the exercise of stock options.